These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8832012)

  • 21. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
    Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease.
    Vion AC; Rautou PE; Durand F; Boulanger CM; Valla DC
    Semin Thromb Hemost; 2015 Sep; 41(6):629-43. PubMed ID: 26305238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
    Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
    Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies.
    Uberti JP; Silver SM; Adams PT; Jacobson P; Scalzo A; Ratanatharathorn V
    Bone Marrow Transplant; 1997 Jun; 19(12):1233-8. PubMed ID: 9208118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
    Lewis ID; DeFor T; Weisdorf DJ
    Bone Marrow Transplant; 2000 Sep; 26(5):539-43. PubMed ID: 11019844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.
    Tsai T; Goodman S; Saez R; Schiller G; Adkins D; Callander N; Wolff S; Freytes CO
    Bone Marrow Transplant; 1997 Nov; 20(10):859-63. PubMed ID: 9404927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term renal function following bone marrow transplantation.
    Grönroos MH; Bolme P; Winiarski J; Berg UB
    Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant.
    Martino R; Caballero MD; de la Serna J; Díez-Martín JL; Urbano-Ispízua A; Tomás JF; Odriozola J; León A; Canals C; San Miguel J; Sierra J
    Bone Marrow Transplant; 2002 Jul; 30(2):63-8. PubMed ID: 12132043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
    Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
    Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
    Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients.
    Aljurf M; Gyger M; Alrajhi A; Sahovic E; Chaudhri N; Musa M; Ayoub O; Seth P; Aslam M; Al-Fiar F
    Bone Marrow Transplant; 1999 Sep; 24(5):551-4. PubMed ID: 10482941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte-macrophage colony-stimulating factor-associated histiocytosis and capillary-leak syndrome following autologous bone marrow transplantation: two case reports and a review of the literature.
    Al-Homaidhi A; Prince HM; Al-Zahrani H; Doucette D; Keating A
    Bone Marrow Transplant; 1998 Jan; 21(2):209-14. PubMed ID: 9489640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment.
    Yuen KY; Woo PC; Hui CH; Luk WK; Chen FE; Lie AK; Liang R
    Bone Marrow Transplant; 1998 Jun; 21(11):1137-43. PubMed ID: 9645577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous versus intravenous low-dose IL-2 therapy after autologous transplantation: results of a prospective, non-randomized study.
    López-Jiménez J; Pérez-Oteyza J; Munoz A; Parra C; Villalón L; Ramos P; Maldonado M; García-Laraña J; Otheo E; Roldán E; García-Avello A; Odriozola J
    Bone Marrow Transplant; 1997 Mar; 19(5):429-34. PubMed ID: 9052907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
    Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.